However, as the insulin signalling pathway is often disrupted in metabolic syndrome including obesity and diabetes,2 it is of great interest to explore insulin‐independent glucose utilizations and therapeutic options as an alternative to resolve the hyperglycaemia and to improve the systemic energy balance. The gene discussed is INS; the disease is diabetes mellitus.